Cobol, Arden A.
HRN: 25-25-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/08/2024
06/14/2024
IV
4.5 G LD Then 2.25 G G
Q8
Infected Wound, CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes